The EPS projection of Clorox Company (The) (NYSE:CLX) for quarter ended 2016-09-30 is $1.38. Last week, the projection for EPS was $1.38 against target of $1.38, a month earlier. While 2-months ago, this projection was $1.38 versus forecast of $1.38a quarter months earlier, posting a deviation of 0%.
Clorox Company (The) (NYSE:CLX) posted that 18 days earlier, the share price was revised 3 times on upside. In addition, negative revisions were 0.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 2, and 1, correspondingly.
The per-share earnings downgrade for Clorox Company (The) (NYSE:CLX) in the preceding 30 and 120 were 0 and 0. While in 60 and 90 days were 0, and 0, in that order.
Clorox Company (The) (NYSE:CLX) EPS target was $1.38 for the quarter closed 3. It was based on 7 calls. As on 2016-05-03 the EPS was $1.21. The change was $0.11, posting a deviation of 10%. The price projections gave a standard deviation of 0.03.
Quarterly Sales Estimates
Clorox Company (The) (NYSE:CLX) sales prediction for the fiscal 2017 stands at $1642.212 and the median estimate is at $1643.425. Almost 4 analysts gave sales target.
Among this, the highest sales estimate is $1668 while the lowest target is $1614 showing standard deviation of 22.281%.
As many as 4 analysts have positive sales targets revision while 4 reduced sales estimates, posting a deviation of 0%.
Last month, 4 experts have positive sales number revision. Also, 4 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast, posting a deviation of 3.243%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...